Leading the way in innovation for over 50 years, we build greater futures for businesses across multiple industries and 131 countries.
Our expert, committed team put our shared beliefs into action – every day. Together, we combine innovation and collective knowledge to create the extraordinary.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
Dr. Alejandra Guerchicoff
Industry Leader – TCS ADD Safety, TCS
Michael Murphy
Executive Director, Head of Pharmacovigilance Operations, Amgen
You have these already downloaded
We have sent you a copy of the report to your email again.
New-age AI technologies and cognitive automation solutions can make the pharmacovigilance (PV) process faster, agile, consistent, accurate, compliant and more efficient. Even though there is no viable “one-size-fits-all” approach to adopting an AI-based PV solution, there is a consensus that technology is an imperative for transforming the PV approach for Life Sciences organizations. We believe the information gathered from our experience clearly presents benefits of AI on operational safety case processing and transformative impact on PV. This paper will guide you to:
Transforming PV Efficiencies with ML and Rule-based Automation
Digital Data Flow and Technological Solution Providers
Next-gen clinical trials on a digital platform
Adopting a Design Thinking Approach for Risk-Based Monitoring
Learn how we can help you bring drugs to the market faster.
Talk to our experts